How to use the speech recognition tool?
An open label dose escalation clinical trial to evaluate the safety and the tolerability of gs010 (rAAV2/2-ND4) in patients with leber hereditary optic neuropathy due to mutations in the mitochondrial nadh dehydrogenase 4 gene.
Status of the trial: Completed
Orphan Drug Recognition: NA
Funder Type: industry
Principal location of the trial
HCP: Principal investigators
HCP: Other investigators